Market Overview

Benzinga's Top Downgrades

Related BMRN
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
BioMarin to Acquire Rights to Phenylketonuria Franchise From Merck Serono for Upfront Payment of €340M, Plus Milestones
Catalyst Starts Congenital Myasthenic Syndromes Study (Zacks)
Related PEG
Benzinga's Top Initiations
Benzinga's Top Initiations

Analysts at Deutsche Bank downgraded BioMarin Pharmaceutical (NASDAQ: BMRN) from “buy” to “hold.” BioMarin's shares closed at $38.70 on Friday. BioMarin's trailing-twelve-month ROE is -11.59%.

Analysts at FBR Capital downgraded Public Service Enterprise Group (NYSE: PEG) from “market perform” to “underperform.” PSEG's stock closed at $32.13 on Friday. PSEG's PEG ratio is 6.66.

Analysts at KeyBanc Capital downgraded Ignite Restaurant Group (NASDAQ: IRG) from “buy” to “hold.” Ignite Restaurant's shares closed at $15.12 on Friday. Ignite Restaurant's trailing-twelve-month profit margin is 2.99%.

UBS downgraded Westlake Chemical (NYSE: WLK) from “neutral” to “sell.” Westlake Chemical's shares closed at $69.50 on Friday. Westlake Chemical's trailing-twelve-month ROA is 9.24%.

Latest Ratings for BMRN

Oct 2015Raymond JamesInitiates Coverage onOutperform
Aug 2015JefferiesMaintainsBuy
Aug 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (BMRN + IRG)

Get Benzinga's Newsletters